RRAD
(Ras-Related Associated with Diabetes (RRAD))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-RRAD antibody (Catalog #: ARP56567_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
RRAD
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
RRAD
(Ras-Related Associated with Diabetes (RRAD))
Synonyme
ZGC:63471 Peptide, RRAD Peptide, RAD Peptide, RAD1 Peptide, REM3 Peptide, Rad Peptide, RRAD, Ras related glycolysis inhibitor and calcium channel regulator Peptide, Ras-related associated with diabetes Peptide, RRAD Peptide, Rrad Peptide
Hintergrund
RRAD may play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. RRAD regulates voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. RRAD inhibits cardiac hy
Alias Symbols: RAD, RAD1, REM3
Protein Interaction Partner: CALM1,CAMK2G,CSNK2A1,NME1,PRKACA,PRKCA,PRKCB,TPM2,YWHAZ,CAMK2G,NME1,TPM2,Tpm2,YWHAZ